Refine by
Anthrax Vaccine Equipment & Supplies
6 equipment items found
Manufactured by:BlueWillow Biologics based inAnn Arbor, MICHIGAN (USA)
Anthrax, though most commonly occurring in animals, can be extremely deadly to humans. Current vaccines can cause acute side effects and may provide only partial protection against some anthrax strains. Tests demonstrate that BlueWillow’s proprietary nanoemulsion (NE) adjuvant could deliver the next generation of anthrax ...
Manufactured by:Emergent BioSolutions Inc. based inGaithersburg, MARYLAND (USA)
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. ...
Manufactured by:Altimmune Inc. based inGaithersburg, MARYLAND (USA)
An intranasal vaccine designed to provide rapid, stable protection against anthrax after a single administration. It is being developed with the support of the U.S. Biomedical Advanced Research and Development Authority, (“BARDA”) for post-exposure prophylaxis against anthrax following exposure to aerosolized B. anthracis ...
Manufactured by:Altimmune Inc. based inGaithersburg, MARYLAND (USA)
Identical vector technology used for AdCOVID (COVID-19), NasoVAX (seasonal influenza) and NasoShield (anthrax) ...
Manufactured by:Emergent BioSolutions Inc. based inGaithersburg, MARYLAND (USA)
ANTHRASIL is a clear to opalescent sterile liquid of purified immune globulin G (IgG) fraction of human plasma containing polyclonal antibodies that bind the protective antigen (PA) component of Bacillus anthracislethal and edema toxins.ANTHRASIL is prepared using plasma collected from healthy, screened donors who were immunized with BioThrax®(Anthrax Vaccine ...
Manufactured by:BlueWillow Biologics based inAnn Arbor, MICHIGAN (USA)
BlueWillow’s intranasal vaccine technology has demonstrated safety and immunogenicity in Phase 1 clinical studies using a seasonal influenza vaccine. Several other ongoing BlueWillow programs — including intranasal vaccines for anthrax, pandemic influenza, RSV, HSV-2 and chlamydia — have recently advanced ...